HB8205: Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
- Introduced (completed)
- Passed One Chamber (completed)
- 3Passed Both Chambers (current step)
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
To amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, and for other purposes.
Plain-language summary
This bill extends an existing federal program helping people with ALS access experimental treatments through 2031. ALS is a progressive disease affecting nerve cells that control muscle movement. The bill renews funding and authorization for the Accelerating Access to Critical Therapies for ALS Act, which currently expires sooner. The bill has passed the House and now awaits Senate consideration.
AI-generated summary
What can I do?
This bill has passed both chambers — a signature or veto decides what happens next.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
HB8205: Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Upcoming hearings & events
Sponsors
Mike Quigley
Primary SponsorCo-sponsors (103)
Ken Calvert
Brian Fitzpatrick
Janice Schakowsky
Michael McCaul
Jake Auchincloss